Damdamon, Bajari D.
HRN: 23-66-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/08/2025
06/15/2025
ORAL
3ml
Q8
AGE With Moderate Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes